Innovation community at The Oxford Science Park expands further as companies move into the Hayakawa Building

 New occupiers include CyanoCapture and Ochre Bio

Oxford, UK, May 16 2022  – The innovation community at The Oxford Science Park, one of Europe’s leading locations for science and technology companies, continues to expand as firms move into the newly refurbished Hayakawa Building. In the facility new occupiers CyanoCapture and Ochre Bio are joining MiroBio, MoA Technology and Oxford Nanopore Technologies who are expanding their footprint on the Park, as well as Circassia which is relocating from another building. Both CyanoCapture and Ochre Bio join from the Oxford BioEscalator, meaning that the overwhelming majority of its alumni companies are now located at The Oxford Science Park.

With its existing high specification facilities the Hayakawa Building was rapidly modified for the new occupiers, including a new bespoke chemistry laboratory for liver health company Ochre Bio. The building, which has 36,000 sq ft of clean room, laboratory and office space, is part of TOSP’s portfolio of Innovation Buildings offering flexible terms for start-up companies.  TOSP took over management and control of the building from Sharp Laboratories of Europe at the end of last year.

“Oxford, through the University hospitals and local industry, is a world leader in cutting-edge liver disease research and we are delighted to be able to expand our presence here with our new facility at The Oxford Science Park,” said Jack O’Meara, CEO & Co-Founder, Ochre Bio. “We’re impressed with the team’s speed and efficiency in establishing a high quality laboratory, to enable Ochre to accelerate the development of RNA therapies for chronic liver diseases, a leading cause of death globally.”

“It’s inspiring to be around people who are passionate about what they’re building. The Oxford Science Park is the perfect environment for that. It’s a real privilege to be here.”, added Dr David Kim, CEO and Co-Founder of CyanoCapture.

Rory Maw, CEO of The Oxford Science Park, said, ‘CyanoCapture and Ochre Bio are highly complementary to the other innovative companies on the Park. We welcome them to the Hayakawa Building, which is also providing valuable space for the expansion of existing occupiers.’

–ENDS—

For more information, please contact:

The Oxford Science Park                                                         

Emma Palmer Foster, Strategic Communications Consultant

T: +44 (0)7880 787185

emmapf@oxfordsp.com


Notes to editors

About The Oxford Science Park

The Oxford Science Park is majority owned by Magdalen College, Oxford, upholding its research heritage and its strategy to support discovery, innovation and entrepreneurship. Providing an influential science and technology environment, the Park has ambitious plans to create an additional 500,000+ sq. ft. of office and laboratory space over the next 3 years alongside its strategic partner GIC. This additional capacity will support the growth of businesses already based on the Park, providing flexible workspace accommodation, and enabling new companies to enjoy the Park’s exceptional environment and collegiate and collaborative ethos.

TOSP is home to 2,700 people and more than 130 businesses. These range from start-ups based in the Magdalen Centre innovation hub to major international companies and include Blue Earth Diagnostics, MiroBio, OrganOx, OxSonics Therapeutics, Oxford Nanopore Technologies, OXGENE, ProImmune, Oxford Science Enterprises, Evox Therapeutics, Vaccitech, Exscientia and Intuitive Surgical.

 The Oxford Science Park is located approximately four miles south-east of Oxford city centre, just off the City’s southern ring road. It has easy access to the M40 and A34, as well as to Heathrow Airport and mainline train services. For further information, please visit: www.oxfordsp.com or follow us on twitter @OxfordSciencePK

Share this page!